BE1002295A5 - Medicaments. - Google Patents
Medicaments. Download PDFInfo
- Publication number
- BE1002295A5 BE1002295A5 BE8900740A BE8900740A BE1002295A5 BE 1002295 A5 BE1002295 A5 BE 1002295A5 BE 8900740 A BE8900740 A BE 8900740A BE 8900740 A BE8900740 A BE 8900740A BE 1002295 A5 BE1002295 A5 BE 1002295A5
- Authority
- BE
- Belgium
- Prior art keywords
- methyl
- drugs
- cylco
- carbazol
- piroxicam
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 abstract 2
- FELGMEQIXOGIFQ-UHFFFAOYSA-N Ondansetron Chemical compound CC1=NC=CN1CC1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-UHFFFAOYSA-N 0.000 abstract 1
- 229940121708 Oxygenase inhibitor Drugs 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- AMLYRCOEFHJSFS-UHFFFAOYSA-N carbazol-1-one Chemical compound C1=CC=C2C3=CC=CC(=O)C3=NC2=C1 AMLYRCOEFHJSFS-UHFFFAOYSA-N 0.000 abstract 1
- 238000011260 co-administration Methods 0.000 abstract 1
- 229960000905 indomethacin Drugs 0.000 abstract 1
- 239000003650 oxygenase inhibitor Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229960002702 piroxicam Drugs 0.000 abstract 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888816187A GB8816187D0 (en) | 1988-07-07 | 1988-07-07 | Medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE1002295A5 true BE1002295A5 (fr) | 1990-11-20 |
Family
ID=10640032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE8900740A BE1002295A5 (fr) | 1988-07-07 | 1989-07-06 | Medicaments. |
Country Status (14)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993000074A1 (en) * | 1991-06-26 | 1993-01-07 | Sepracor, Inc. | Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| GB9310756D0 (en) * | 1993-05-25 | 1993-07-14 | Glaxo Lab Sa | Compositions |
| GB9710767D0 (en) * | 1996-06-26 | 1997-07-23 | On Ninh | Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same |
| GB9816899D0 (en) | 1998-08-05 | 1998-09-30 | Boots Co Plc | Therapeutic agents |
| JP2004525083A (ja) * | 2000-10-30 | 2004-08-19 | テバ ファーマシューティカル インダストリーズ リミティド | 塩酸オンダンセトロンの新規結晶及び溶媒和物形態並びにその製法 |
| PL373191A1 (en) * | 2002-04-29 | 2005-08-22 | Teva Gyogyszergyar Reszvenytarsasag | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one |
| US20050131045A1 (en) * | 2002-04-30 | 2005-06-16 | Judith Aronhime | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them |
| WO2004010955A2 (en) * | 2002-07-31 | 2004-02-05 | Sepracor Inc. | Cyclooxygenase-2 inhibitors for appetite suppression |
| JP2010513525A (ja) * | 2006-12-22 | 2010-04-30 | ノヴァデル ファーマ インコーポレイテッド | 安定な抗嘔吐経口噴霧製剤および方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2105193A (en) * | 1981-09-04 | 1983-03-23 | Glaxo Group Ltd | Pharmaceutical compositions containing non-steroidal anti-inflammatory agents |
| EP0272876B1 (en) * | 1986-12-17 | 1993-10-13 | Glaxo Group Limited | Use of heterocyclic derivatives for the manufacture of medicaments |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB105193A (en) * | 1916-08-29 | 1917-04-05 | Thomas Joseph Mills | Improvements in Rotary Printing Machines. |
| AU528098B2 (en) * | 1978-11-16 | 1983-04-14 | Beecham Group Plc | Analgesic tablet |
| US4309408A (en) * | 1978-11-16 | 1982-01-05 | Beecham Group Limited | Effervescent powders |
| DE3689974T2 (de) * | 1985-03-14 | 1994-11-03 | Beecham Group Plc | Arzneimittel zur Behandlung von Emesis. |
| GB8516083D0 (en) * | 1985-06-25 | 1985-07-31 | Glaxo Group Ltd | Heterocyclic compounds |
-
1988
- 1988-07-07 GB GB888816187A patent/GB8816187D0/en active Pending
-
1989
- 1989-07-06 ZA ZA895142A patent/ZA895142B/xx unknown
- 1989-07-06 DK DK336489A patent/DK336489A/da not_active Application Discontinuation
- 1989-07-06 BE BE8900740A patent/BE1002295A5/fr not_active IP Right Cessation
- 1989-07-06 GB GB8915499A patent/GB2220352B/en not_active Expired - Fee Related
- 1989-07-06 DE DE3922263A patent/DE3922263A1/de not_active Withdrawn
- 1989-07-06 CH CH2511/89A patent/CH679553A5/fr not_active IP Right Cessation
- 1989-07-06 FR FR8909113A patent/FR2633831B1/fr not_active Expired - Fee Related
- 1989-07-06 US US07/375,913 patent/US4983621A/en not_active Expired - Fee Related
- 1989-07-06 CA CA000604967A patent/CA1330306C/en not_active Expired - Fee Related
- 1989-07-06 JP JP1175419A patent/JPH0276815A/ja active Pending
- 1989-07-06 IT IT8948163A patent/IT1232155B/it active
- 1989-07-06 AU AU37904/89A patent/AU633496B2/en not_active Ceased
- 1989-07-06 SE SE8902458A patent/SE8902458L/xx not_active Application Discontinuation
- 1989-07-06 NL NL8901727A patent/NL8901727A/nl not_active Application Discontinuation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2105193A (en) * | 1981-09-04 | 1983-03-23 | Glaxo Group Ltd | Pharmaceutical compositions containing non-steroidal anti-inflammatory agents |
| EP0272876B1 (en) * | 1986-12-17 | 1993-10-13 | Glaxo Group Limited | Use of heterocyclic derivatives for the manufacture of medicaments |
Also Published As
| Publication number | Publication date |
|---|---|
| DK336489D0 (da) | 1989-07-06 |
| CA1330306C (en) | 1994-06-21 |
| FR2633831B1 (fr) | 1993-11-19 |
| GB2220352B (en) | 1992-03-18 |
| SE8902458D0 (sv) | 1989-07-06 |
| US4983621A (en) | 1991-01-08 |
| CH679553A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1992-03-13 |
| JPH0276815A (ja) | 1990-03-16 |
| AU3790489A (en) | 1990-01-11 |
| DE3922263A1 (de) | 1990-01-11 |
| DK336489A (da) | 1990-01-08 |
| FR2633831A1 (fr) | 1990-01-12 |
| GB8816187D0 (en) | 1988-08-10 |
| GB8915499D0 (en) | 1989-08-23 |
| GB2220352A (en) | 1990-01-10 |
| NL8901727A (nl) | 1990-02-01 |
| SE8902458L (sv) | 1990-01-08 |
| IT8948163A0 (it) | 1989-07-06 |
| ZA895142B (en) | 1990-06-27 |
| IT1232155B (it) | 1992-01-25 |
| AU633496B2 (en) | 1993-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1002249A4 (fr) | Compositions pharmaceutiques. | |
| IL119627A0 (en) | Controlled-release pharmaceutical preparations | |
| EA200101026A1 (ru) | Предварительно желатинированный крахмал в композиции с контролируемым высвобождением | |
| ES2188782T3 (es) | Formulaciones farmaceuticas que contienen darifenacina. | |
| CA2326517A1 (en) | New galenic preparations of meloxicam for oral administration | |
| YU13695A (sh) | Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije | |
| RU94032150A (ru) | Лекарственное средство с замедленным высвобождением активно-действующего вещества | |
| CA2105180A1 (en) | Compositions containing sumatriptan | |
| EP1365749A4 (en) | PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS | |
| DK0724885T3 (da) | Pernasal sammensætning og pernasalt præparat indeholdende dette | |
| BE1002295A5 (fr) | Medicaments. | |
| RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
| NO912416D0 (no) | Terapeutisk aktiv benzimidazolforbindelse og fremgangsmaate for dens fremstilling. | |
| KR880007074A (ko) | 의약품 | |
| JPH1036269A (ja) | 月経困難症及び／又は月経前症候群の軽減用薬剤 | |
| PT1027053E (pt) | Metodo de prevencao de nefrotoxicidade provocada por ciclosporinas e tacrolimus | |
| BE1002255A5 (fr) | Medicaments. | |
| FR2660192B1 (fr) | Formulation liposomiales pour l'administration topique ou vaginale de medicaments. | |
| CA2135179A1 (en) | Pharmaceutical Compositions of Alkylsulphonamides 5HT1 Agonists for Rectal Administration | |
| BE1002256A3 (fr) | Medicaments. | |
| BE1002182A5 (fr) | Compositions pharmaceutiques. | |
| JPH0314812B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| GEP20043377B (en) | Pharmaceutical Complex | |
| HUP9901935A2 (hu) | Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet | |
| CA2259270A1 (en) | Pharmaceutical preparation containing nimesulide for oral administration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: GLAXO GROUP LTD Effective date: 19950731 |